Thursday, November 26
Welcome remarks from IFLR
9:00 HKT
Overview of the capital markets space in Asia
-
Should we look in creating a more transparent market?
-
Global political landscape affecting the appetite of various banks with lending
-
Recent amendments from SEC on disclosure

Kris Daswani
Head legal, transaction banking, Standard Chartered

Stanley Park
Managing director & head of legal, Asia-Pacific, Scotiabank

Lifen Tang
General counsel, TransAsia Private Capital
Coffee break
10:05-10:30 HKT
Deal flow in equity capital markets
Analysing the US-China market deal flow
Seeking secondary listing in outside of the US
Practical impacts of data sharing restrictions and producing reports to foreign regulators
How investments are impacted with the new regional FDI controls

Stephen Monick
Investment banking counsel, Bank of America

Raymond Goh
Group general counsel, international, China Tourism Group

En Hong
Chief compliance officer and counsel, Ward Ferry Management

Yongkai Wong
Managing director, head of special projects, & co-general counsel, CITIC Capital

Yilong Du
General counsel, China and South East Asia, Warburg Pincus
Lunch break
11:30-14:00 HKT
Lunch and networking
12:30-13:30 HKT
A look at the bond market
-
Investing in ESG/Covid bonds
-
Recent developments on keepwell structure
-
New HKEX listing rules for bonds
-
Impact of sanctions on bond market

Jessica Zhou
Partner, White & Case

Alexander Shaik
Partner, general counsel, Asia-Pacific private credit, ADM Capital

Shaun Ansell
Head of legal and compliance, Asia-Pacific, GBP Financial Services

Yvette Rodriguez
Director and associate general counsel, Deutsche Bank AG

Esther Wong
Associate general counsel, legal - transaction management, global banking, Asia Pacific, HSBC
Coffee break
15:00-15:30 HKT
Debate: pros and cons of a listing venue
This session looks at the key factors to take into account when choosing a listing venue. What are the major developments that has changed in the past year that make companies so indecisive?

George Lin
CFO, Hua Medicine

Danny Kan
Chief counsel, listing & compliance, cum joint company secretary, Ping An Group
End of conference
16:00 HKT
Reviewing the biotech listings on the HKEX
How well have they performed and lessons learned
Key trends in the biotech market
Reactions to the pandemic and the listing of healthcare companies
Post-event virtual networking
15:45 HKT
Back to top